| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327329 | Gynecologic Oncology | 2005 | 4 Pages |
Abstract
The identification of a hormone sensitive disease is the main clinical implication of this study. Moreover, the current results add OAS to the list of CD10 positive ovarian tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Tim Van Mieghem, Vera M. Abeler, Philippe Moerman, Lieve Verbist, Ignace Vergote, Frederic Amant,